Tracleer — Medical Mutual
Chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group 4
Initial criteria
- The request is for bosentan (Tracleer, generic); AND
 - The medication is prescribed by or in consultation with a cardiologist or pulmonologist; AND
 - Patient has tried Adempas; OR use of Adempas is contraindicated; OR patient is currently receiving bosentan; AND
 - The patient has been treated surgically or CTEPH is inoperable; AND
 - For brand Tracleer, the patient has failed a trial of generic bosentan and/or the patient cannot take generic bosentan due to a formulation difference in the inactive ingredient(s) which would result in a significant allergy or serious adverse reaction per the prescribing physician
 
Approval duration
1 year